Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

INTERMOLECULAR INC (IMI) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/30/2019 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
09/24/2019 4 MARTIN WILLIAM C (10% Owner) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 14,731,351 shares @ $1.2, valued at $17.7M
09/24/2019 SC 13D/A Raging Capital Management, LLC reports a 0% stake in Intermolecular, Inc.
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/20/2019 4 Furnas Matthew (Director) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 75,000 options @ $0.96, valued at $72k
Unknown transaction of 25,000 options @ $1.39, valued at $34.8k
09/20/2019 4 BURKETT MARVIN D (Director) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 12,500 options @ $6.2, valued at $77.5k
Unknown transaction of 10,000 options @ $6.62, valued at $66.2k
Unknown transaction of 10,000 options @ $8.21, valued at $82.1k
Unknown transaction of 10,000 options @ $2.59, valued at $25.9k
Unknown transaction of 25,000 options @ $1.82, valued at $45.5k
Unknown transaction of 25,000 options @ $1.85, valued at $46.3k
Unknown transaction of 25,000 options @ $0.85, valued at $21.3k
Unknown transaction of 25,000 options @ $1.39, valued at $34.8k
09/20/2019 4 TRAUB KENNETH H (Director) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 75,000 options @ $1.85, valued at $138.8k
Unknown transaction of 25,000 options @ $0.85, valued at $21.3k
Unknown transaction of 25,000 options @ $1.39, valued at $34.8k
09/20/2019 4 Schultz Jonathan B. (Director) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 75,000 options @ $1.39, valued at $104.3k
09/20/2019 4 FEDERMAN IRWIN (10% Owner) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 538,267 shares @ $0
Unknown transaction of 10,000 options @ $6.62, valued at $66.2k
Unknown transaction of 10,000 options @ $8.21, valued at $82.1k
Unknown transaction of 10,000 options @ $2.59, valued at $25.9k
Unknown transaction of 25,000 options @ $1.82, valued at $45.5k
Unknown transaction of 25,000 options @ $1.85, valued at $46.3k
Unknown transaction of 25,000 options @ $0.85, valued at $21.3k
Unknown transaction of 25,000 options @ $1.39, valued at $34.8k
09/20/2019 4 SCALISE GEORGE (Director) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 160,000 shares @ $0
Unknown transaction of 10,000 options @ $6.62, valued at $66.2k
Unknown transaction of 10,000 options @ $8.21, valued at $82.1k
Unknown transaction of 10,000 options @ $2.59, valued at $25.9k
Unknown transaction of 25,000 options @ $1.82, valued at $45.5k
Unknown transaction of 25,000 options @ $1.85, valued at $46.3k
Unknown transaction of 25,000 options @ $0.85, valued at $21.3k
Unknown transaction of 25,000 options @ $1.39, valued at $34.8k
09/20/2019 4 Kramer Christian (President and CEO) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 850,000 shares @ $0
Unknown transaction of 1,000,000 options @ $1.35, valued at $1.4M
Unknown transaction of 200,000 options @ $0.83, valued at $166k
Unknown transaction of 150,000 options @ $1.3501, valued at $202.5k
09/20/2019 4 ROESCHLEIN BILL (CFO) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 260,000 shares @ $0
Unknown transaction of 100,000 options @ $2.04, valued at $204k
Unknown transaction of 54,000 options @ $0.99, valued at $53.5k
Unknown transaction of 250,000 options @ $0.9, valued at $225k
Unknown transaction of 60,000 options @ $1.3501, valued at $81k
09/20/2019 4 Scheer Adam Louis Abraham (Director) has filed a Form 4 on INTERMOLECULAR INC
Txns: Unknown transaction of 75,000 options @ $1.39, valued at $104.3k
09/20/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
09/20/2019 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Intermolecular, Inc",
"Amended and Restated Bylaws of Intermolecular, Inc"
08/14/2019 SC 13D/A Merck KGaA reports a 31% stake in INTERMOLECULAR, INC.
08/08/2019 10-Q Quarterly Report for the period ended June 30, 2019
08/08/2019 8-K Quarterly results
Docs: "Intermolecular Reports Second Quarter 2019 Financial Results"
07/17/2019 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Intermolecular Stockholders Approve Merck KGaA, Darmstadt, Germany's Proposed Acquisition of Intermolecular"
06/28/2019 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/17/2019 GN Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Intermolecular, Electronics for Imaging, El Paso Electric, and Gardner Denver on Behalf of Stockholders and Encourages Investors to Contact the Firm
06/12/2019 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
06/06/2019 GN ZAYO, CHSP, IMI Merger Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – ZAYO, CHSP, IMI
05/28/2019 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
05/16/2019 SC 13D Merck KGaA reports a 31% stake in INTERMOLECULAR, INC.
05/16/2019 SC 13D GAMCO INVESTORS, INC. ET AL reports a 3.6% stake in Intermolecular, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy